Delivery Order SPE2DB20D2001-SPE2DB25FPMQP

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $19,727.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 11, 2025. This contract is not set aside and was awarded through open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,255.59 firm fixed-price delivery order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of May 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,657.33 delivery order contract is for the provision of Nurtec ODT 75 mg tablets, a prescription medication used for the treatment of migraines. The contract is not set aside and is a firm fixed-price, delivery order type. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $21,024.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order (SPE2DB25FUXEQ) under Amerisourcebergen's existing Indefinite Delivery Contract (SPE2DB25D3018) with DLA, which has a ceiling value of $999,999,999.00 and provides comprehensive global pharmaceutical support through December 2026. The current delivery order is for the supply of Nurtec ODT 75 mg...
This federal contract award, valued at $3,784.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Nurtec ODT 75 mg tablets, a medication used for the treatment of migraines. The contract is a delivery order with a firm fixed-price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is open to competition. AmerisourceBergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has a ceiling value of $27,277.47 and a completion date of September 20, 2023. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $13,958.62. The order is for Nurtec ODT 75 mg tablets, a medication used to treat migraine. The contract has a firm fixed price and a completion date of June 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,110.24 firm fixed-price contract is for the delivery of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract has an ultimate completion date of April 9, 2025 and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and this award is part of a larger $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,778.79 firm fixed-price delivery order is for Nurtec ODT 75 mg tablets, a medication used for the treatment of migraine. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $17,769.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is not set-aside and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPMQP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,008.04 Delivery Order is for the supply of Nurtec ODT 75 mg tablets, a medication used to treat migraines. The contract is a Firm Fixed Price arrangement with a completion date of May 8, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of medical products and supplies to military healthcare programs through December 2026. The contract does not have a set-aside designation, indicating open competition.

Generated 8/6/25, 9:55 AM